$207.880
-12.473 (-6.00%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de RVMD por análisis de gráficos similares
Alphio's RVMD stock price prediction model matches the current Revolution Medicines Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $212.72 (+2.33%). The 1-week path is $217.32 (+4.54%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Revolution Medicines Inc?
Revolution Medicines Inc is a good buy right now due to the recent FDA approval of its drug Rasonque, which is projected to generate $28 million in sales this quarter and has a long-term sales potential of $11.5 billion. Additionally, the stock has seen a remarkable year-to-date change of +163.07% and is currently priced at $207.88, with analysts raising price targets significantly, indicating strong future upside.
RVMD cerró en $207.88 el Friday, tras bajar -6.00%
Revolution Medicines Inc (RVMD) last closed at $207.88, losing -6.00%. These facts feed the 1-day and 1-week RVMD price prediction above.
Factores de la previsión
Los factores de la previsión de Revolution Medicines Inc (RVMD) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de RVMD, ordenadas por similitud.
Análisis de estacionalidad de RVMD
Historically the probability of a positive August return for RVMD is 66.67%. October offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.